IL-8RCRISPRプラスミド
サンタクルスバイオテクノロジー社は遺伝子サイレンシング用のCRISPR/Cas9ノックアウト及びCRISPR Double Nickaseプラスミドを含め、広範囲の遺伝子編集製品を提供しております。IL-8R遺伝子サイレンサーは、IL-8R CRISPR/Cas9ノックアウトプラスミドとIL-8RDouble Nickaseプラスミドとして利用可能です。遺伝子活性化用のIL-8RCRISPR/dCas9 Activationプラスミド及びCRISPR Lenti Activationシステムも利用できます。遺伝子サイレンサーと活性化剤はタンパク質の検出に使用された抗体と組み合わせた遺伝子研究に有用です。
IL-8R CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
IL-8RA CRISPR/Cas9 KOプラスミド (h) | sc-401645 | h | Gene Knockout | GFP | 0 | ||
IL-8RA HDRプラスミド (h) | sc-401645-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
IL-8RA Double Nickaseプラスミド (h) | sc-401645-NIC | h | Gene Knockout | Puromycin | 0 | ||
IL-8RA Double Nickaseプラスミド (h2) | sc-401645-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
IL-8RA CRISPR/Cas9 KOプラスミド (m) | sc-432684 | m | Gene Knockout | GFP | 0 | ||
IL-8RA HDRプラスミド (m) | sc-432684-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
IL-8RA Double Nickaseプラスミド (m) | sc-432684-NIC | m | Gene Knockout | Puromycin | 0 | ||
IL-8RA Double Nickaseプラスミド (m2) | sc-432684-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
IL-8RB CRISPR/Cas9 KOプラスミド (h) | sc-401404 | h | Gene Knockout | GFP | 1 | ||
IL-8RB HDRプラスミド (h) | sc-401404-HDR | h | Homology Directed Repair | Puromycin | 1 | ||
IL-8RB Double Nickaseプラスミド (h) | sc-401404-NIC | h | Gene Knockout | Puromycin | 1 | ||
IL-8RB Double Nickaseプラスミド (h2) | sc-401404-NIC-2 | h | Gene Knockout | Puromycin | 1 | ||
IL-8RB CRISPR/Cas9 KOプラスミド (m2) | sc-419698-KO-2 | m | Gene Knockout | GFP | 0 | ||
IL-8RB HDRプラスミド (m2) | sc-419698-HDR-2 | m | Homology Directed Repair | Puromycin | 0 | ||
IL-8RB Double Nickaseプラスミド (m) | sc-419698-NIC | m | Gene Knockout | Puromycin | 0 | ||
IL-8RB Double Nickaseプラスミド (m2) | sc-419698-NIC-2 | m | Gene Knockout | Puromycin | 0 |
IL-8R CRISPR Activation Products
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
IL-8RA CRISPR Activationプラスミド (h) | sc-401645-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-8RA CRISPR Activationプラスミド (h2) | sc-401645-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-8RA Lentiviral Activation Particles (h) | sc-401645-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-8RA Lentiviral Activation Particles (h2) | sc-401645-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-8RA CRISPR Activationプラスミド (m) | sc-432684-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-8RA CRISPR Activationプラスミド (m2) | sc-432684-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-8RA Lentiviral Activation Particles (m) | sc-432684-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-8RA Lentiviral Activation Particles (m2) | sc-432684-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-8RB CRISPR Activationプラスミド (h) | sc-401404-ACT | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
IL-8RB CRISPR Activationプラスミド (h2) | sc-401404-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
IL-8RB Lentiviral Activation Particles (h) | sc-401404-LAC | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
IL-8RB Lentiviral Activation Particles (h2) | sc-401404-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
IL-8RB CRISPR Activationプラスミド (m) | sc-419698-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-8RB CRISPR Activationプラスミド (m2) | sc-419698-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-8RB Lentiviral Activation Particles (m) | sc-419698-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-8RB Lentiviral Activation Particles (m2) | sc-419698-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |